CATALYSIS SL
🇪🇸Spain
Diamel in the Treatment of Type 2 Diabetic Patients Receiving Insulin Therapy
Phase 3
Completed
- Conditions
- Type 2 Diabetes
- Interventions
- Dietary Supplement: DiamelDietary Supplement: Placebo
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2011-04-29
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 116
- Registration Number
- NCT00994266
- Locations
- 🇨🇺
Diabetes Care Center. "Abel SantamarÃa Cuadrado" General Hospital, Pinar del RÃo, Cuba
CICATRIX in the Treatment of Hypertrophic Scars and Keloids Scars
Phase 3
Completed
- Conditions
- Hypertrophic ScarsKeloids
- Interventions
- Other: CicatrixOther: Placebo
- First Posted Date
- 2009-10-09
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 90
- Registration Number
- NCT00993005
- Locations
- 🇨🇺
"Cdte. Manuel Fajardo Rivero" Clinical-Surgical-Docent Hospital, Havana City, Havana, Cuba
CICATRIX in the Treatment of Recent Post-surgical Scars
Phase 3
Completed
- Conditions
- Post-surgical Scars
- Interventions
- Other: CicatrixOther: Placebo
- First Posted Date
- 2009-10-08
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 90
- Registration Number
- NCT00991367
- Locations
- 🇨🇺
"Cdte. Manuel Fajardo Rivero" Clinical-Surgical-Docent Hospital, Havana City, Havana, Cuba
Retorna Facial Cream in the Treatment of Facial Wrinkles
Phase 3
Completed
- Conditions
- Facial Wrinkles
- Interventions
- Other: RetornaOther: Placebo
- First Posted Date
- 2009-09-17
- Last Posted Date
- 2010-05-18
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 148
- Registration Number
- NCT00978887
- Locations
- 🇨🇺
"Commander Manuel Fajardo Rivero" Hospital, Havana City, Havana, Cuba
Viusid Administration in Subjects With Chronic Inflammatory Syndrome Under Hemodialysis Treatment
Phase 3
Suspended
- Conditions
- Chronic Inflammatory Syndrome
- Interventions
- Dietary Supplement: ViusidDietary Supplement: Placebo
- First Posted Date
- 2009-09-16
- Last Posted Date
- 2010-07-07
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 152
- Registration Number
- NCT00978224
- Locations
- 🇨🇺
Institute of Nephrology "Dr. Abelardo Buch López", Havana, Cuba
Spermotrend in the Treatment of Male Infertility
Phase 3
Completed
- Conditions
- Male Infertility
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Spermotrend
- First Posted Date
- 2009-09-11
- Last Posted Date
- 2011-03-08
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 86
- Registration Number
- NCT00975117
- Locations
- 🇨🇺
"Ramón González Coro" Gynecologic and Obstetric Hospital, Havana, Cuba
Efficacy of Oncoxin Plus Viusid in the Treatment of Rheumatoid Arthritis
Phase 3
Completed
- Conditions
- Rheumatoid Arthritis
- Interventions
- Dietary Supplement: Oncoxin + ViusidDietary Supplement: Placebo
- First Posted Date
- 2009-09-01
- Last Posted Date
- 2011-05-09
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 86
- Registration Number
- NCT00969527
- Locations
- 🇨🇺
Fructuoso Rodriguez Orthopedic Hospital, Havana, Cuba
Efficacy and Safety of ONCOXIN in Patients With Breast Fibrocystic Disease
Phase 3
Completed
- Conditions
- Breast Fibrocystic Disease
- Interventions
- Dietary Supplement: OncoxinDietary Supplement: Placebo
- First Posted Date
- 2009-08-28
- Last Posted Date
- 2012-05-04
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 200
- Registration Number
- NCT00967681
- Locations
- 🇨🇺
"Ramón González Coro" Gynecologic and Obstetric Hospital, Havana, Cuba
Efficacy and Safety of Diamel in Patients With Nonalcoholic Steatohepatitis
Phase 3
Completed
- Conditions
- Insulin ResistanceNonalcoholic Steatohepatitis
- Interventions
- Other: Placebo and lifestyle counselingDietary Supplement: Diamel
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2012-04-26
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 158
- Registration Number
- NCT00820651
- Locations
- 🇨🇺
National Institute of Gastroenterology, Vedado, Havana, Cuba
Antioxidant and Immunomodulator Properties of Viusid in Patients With Chronic Hepatitis C
Phase 3
Completed
- Conditions
- Chronic Hepatitis C
- Interventions
- Dietary Supplement: ViusidOther: Placebo
- First Posted Date
- 2008-10-23
- Last Posted Date
- 2012-05-04
- Lead Sponsor
- Catalysis SL
- Target Recruit Count
- 60
- Registration Number
- NCT00778843
- Locations
- 🇨🇺
National Institute of Gastroenterology, Vedado, Havana, Cuba
© Copyright 2025. All Rights Reserved by MedPath